ovarian mucinous cystadenocarcinoma

Showing 1 - 15 of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +19 more
  • Hartford, Connecticut
  • +13 more
Aug 8, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Japan, United States (procedure, drug,

Completed
  • Brenner Tumor
  • +11 more
  • adjuvant therapy
  • +3 more
  • Orange, California
  • +18 more
Jul 19, 2019

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,

Terminated
  • Nausea and Vomiting
  • +26 more
  • Adjuvant Therapy
  • +7 more
  • Hinsdale, Illinois
  • +1 more
Apr 24, 2018

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Seattle (biological, drug, other)

Completed
  • Brenner Tumor
  • +11 more
  • sargramostim
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 24, 2017

Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in

Terminated
  • Malignant Ovarian Mixed Epithelial Tumor
  • +7 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Aug 8, 2017

Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor Trial in Philadelphia (Carboplatin,

Completed
  • Fallopian Tube Carcinoma
  • +10 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 7, 2015

Fatigue, Malignant Ovarian Mixed Epithelial Tumor, Neuropathy Trial (Acetyl-L-Carnitine Hydrochloride, Placebo, Questionnaire

Withdrawn
  • Fatigue
  • +12 more
  • Acetyl-L-Carnitine Hydrochloride
  • +3 more
  • (no location specified)
Dec 29, 2014

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,

Terminated
  • Adenocarcinoma of the Pancreas
  • +25 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Apr 1, 2014

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Phoenix (paclitaxel,

Completed
  • Brenner Tumor
  • +8 more
  • Phoenix, Arizona
    Gynecologic Oncology Group of Arizona
Jan 23, 2013